Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info


Read Full Text


Download PDF


View Table of Contents

Influence of Interleukin 10 Promoter Polymorphisms in Susceptibility to Giant Cell Arteritis in Northwestern Spain

BLANCA RUEDA, BEGOÑA ROIBAS, JAVIER MARTIN, and MIGUEL A. GONZALEZ-GAY

ABSTRACT.

Objective.
Proinflammatory cytokines such as interferon-g (IFN-g) play an important role in the pathogenesis of giant cell arteritis (GCA). Interleukin 10 (IL-10) is a Th2 cytokine with a suppressor effect on IFN-g production. We assessed the influence of functional IL-10 gene promoter polymorphisms in susceptibility to GCA in individuals from Northwestern Spain.

Methods. One hundred three patients with biopsy-proven GCA and 226 matched controls from the Lugo region of Northwest Spain were genotyped for IL-10 –1082 G/A (rs1800896) and –592 C/A (rs1800872) promoter single nucleotide polymorphisms (SNP) by Taqman 5' allelic discrimination assay using Taqman predesigned SNP genotyping assays (numbers C_1747360_10 and C_1747363_10, respectively).

Results. A significant difference in the distribution of –1082 G/A genotypes between GCA patients and controls was observed (p = 0.034). It was mainly due to a decreased number of GCA patients carrying the –1082 A/A genotype (23.3%) compared with controls (36.7%) [p = 0.01, corrected p (pc) = 0.03; OR 0.53, 95% CI 0.31– 0.90]. In addition, haplotype analysis showed that the ATA haplotype frequency was slightly decreased (p = 0.05, pc = 0.2; OR 0.6, 95% CI 0.4–1.0), whereas the uncommon GTA haplotype was significantly increased in GCA patients compared with controls (p = 0.00005, pc = 0.0002; OR 8.7, 95% CI 2.2–34.8).

Conclusion. Our results suggest a potential implication of IL-10 –1082 promoter polymorphism in susceptibility to GCA in Northwestern Spain. (First Release June 1 2007; J Rheumatol 2007:34:1535-9)

Key Indexing Terms:

GIANT CELL (TEMPORAL) ARTERITIS
TEMPORAL ARTERY BIOPSY
INTERLEUKIN 10
GENE POLYMORPHISMS


From the Consejo Superior de Investigaciones Cientificas (CSIC), Granada; and Division of Rheumatology, Hospital Xeral-Calde, Lugo, Spain.

Dr. Gonzalez-Gay and Dr. Martin share senior authorship in this study.

B. Rueda, PhD; B. Roibas, BSc; J. Martin, MD, PhD, Consejo Superior de Investigaciones Cientificas; M.A. Gonzalez-Gay, MD, PhD, Division of Rheumatology, Hospital Xeral-Calde.

Address reprint requests to Dr. M.A. Gonzalez-Gay, Rheumatology Division, Hospital Xeral-Calde, c) Dr. Ochoa s/n, 27004, Lugo, Spain. E-mail: miguelaggay@hotmail.com

Accepted for publication March 12, 2007.




Return to July 2007 Table of Contents



© 2007. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.